Louthrenoo, Worawit http://orcid.org/0000-0003-3105-6122
Nilganuwong, Surasak
Nanagara, Ratanavadee
Siripaitoon, Boonjing
Collaud Basset, Sabine
Funding for this research was provided by:
TRB Chemedica (Thailand) Ltd. (DAR-THA-05-01)
Article History
Received: 14 February 2019
Revised: 12 April 2019
Accepted: 1 May 2019
First Online: 19 May 2019
Compliance with ethical standards
:
: Worawit Louthrenoo and Boonjing Siripaitoon received speaking honoraria from TRB Chemedica (Thailand) Ltd. Sabine Collaud Basset is an employee of TRB Chemedica International SA, Switzerland. Surasak Nilganuwong and Ratanavadee Nanagara declared no conflicts of interest.
: All patients gave their informed consent prior to enter the clinical trial, i.e., before they underwent any study procedure at the screening visit.
: The trial was conducted in accordance with the Good Clinical Practices and was compliant with the principles of the 1983 Declaration of Helsinki. Ethics approval was provided by the Institutional Review Boards of the four participating centers. The study has been registered in the ExternalRef removed National Institute of Health trial register (NCT01264211).